Free Trial

Nemaura Medical (NMRD) Insider Trading & Ownership

Nemaura Medical logo

Nemaura Medical (NASDAQ:NMRD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
40.42%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$14,000.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get NMRD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nemaura Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NMRD Insider Buying and Selling by Quarter

Nemaura Medical Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/5/2024Arash Ghadar-GhadrCOOBuy100,000$0.14$14,000.00  
(Data available from 1/1/2013 forward)

NMRD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Nemaura Medical includes Arash Ghadar-Ghadr. Learn more on insiders at NMRD.

40.42% of Nemaura Medical stock is owned by insiders. Learn more on NMRD's insider holdings.

The following insider purchased NMRD shares in the last 24 months: Arash Ghadar-Ghadr ($14,000.00).

Insiders have purchased a total of 100,000 NMRD shares in the last 24 months for a total of $14,000.00 bought.

Nemaura Medical Key Executives

  • Dr. Dewan Fazlul Hoque Chowdhury Ph.D. (Age 51)
    Chairman, Interim CFO, CEO, President and Principal Financial & Accounting Officer
    Compensation: $338.58k
  • Dr. Arash Ghadar (Age 47)
    Chief Operating Officer
  • Mr. Jay L. Warner
    Head of U.S. Commercial Operations
  • Mr. Thomas Bendix Mortensen
    Head of E.U. Commercial Operations & Marketing
  • Ms. Samantha Sanders
    Global Head of Digital Programs


This page (NASDAQ:NMRD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners